This article needs additional citations for verification. (September 2014) (Learn how and when to remove this template message)
(Doyle, 1948) Véron and Chatelain, 1973
C. coli grows slowly with an optimum temperature of 42 °C. When exposed to air for long periods, they become spherical or coccoid shaped.
At least a dozen species of Campylobacter have been implicated in human disease (campylobacteriosis), with C. jejuni and C. coli the most common. In humans, 85% to 95% of infections by the Campylobacter species involve C. jejuni, while C. coli is involved in a majority of the other cases. The bacterium is often found in pigs but can also infect humans and a wide range of animals such as cattle, sheep, and bird. Similar to the C. jejuni, C. coli has the ability to cause enteritis with symptoms such as abdominal pain, diarrhea, bloody stool, vomiting and fever. These symptoms are caused, in part, by a secreted cytolethal distending toxin. A variety of antibiotics have been found to be effective against the bacterium, including but not limited to chloramphenicol, nitofurantoin, and tetracycline. Emerging new strains were reported to be resistant to fluoroquinolones, macrolides, trimethoprim, beta lactams, tetracycline, quinolone, and kanamycin.
- Lansing M. Prescott, John P. Harley, and Donald A. Klein, 2005. Campylobacter. Microbiology 6th Edition 430-433, 500.
- Public Health Agency of Canada (2011). "Campylobacter coli". www.phac-aspc.gc.ca. Retrieved 22 May 2017.
- National Center for Biotechnology Information, 2007. Genome Project. National Center for Biotechnology Information Web Site
- Alfredson, David A.; Korolik, Victoria (2007-12-01). "Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli". FEMS Microbiology Letters. 277 (2): 123–132. doi:10.1111/j.1574-6968.2007.00935.x. ISSN 0378-1097. PMID 18031331.
|This Epsilonproteobacteria-related article is a stub. You can help Wikipedia by expanding it.|